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Abstract: Postprandial inflammation and endotoxaemia are determinants of cardiovascular and
metabolic disease risk which are amplified by high fat meals. We aimed to examine the determinants
of postprandial inflammation and endotoxaemia in older and younger adults following a high fat
mixed meal. In a randomised cross-over trial, healthy participants aged 20–25 and 60–75 years
(n = 15/group) consumed a high-fat breakfast and a low-fat breakfast. Plasma taken at baseline and
post-meal for 5 h was analysed for circulating endotoxin, cytokines (monocyte chemotactic protein-1
(MCP-1), interleukin (IL)-1β, IL-6, and tumour necrosis factor-alpha (TNF-α)), lipopolysaccharide
binding protein (LBP), and inflammatory gene expression in peripheral blood mononuclear cells
(PBMC). Older subjects had lower baseline PBMC expression of glutathione peroxidase 1 (GPX-1) but
greater insulin-like growth factor-binding protein 3 (IGFBP3) and circulating MCP-1 compared to
younger subjects. After either meal, there were no age differences in plasma, chylomicron endotoxin,
or plasma LBP concentrations, nor in inflammatory cytokine gene and protein expression (MCP-1,
IL-1β, and TNF-α). Unlike younger participants, the older group had decreased superoxide dismutase
(SOD)-2 expression after the meals. After a high-fat meal, older adults have no increased inflammatory
or endotoxin response, but an altered oxidative stress gene response compared with younger adults.
Healthy older adults, without apparent metabolic dysfunction, have a comparable postprandial
inflammatory and endotoxaemia response to younger adults.
Keywords: ageing; endotoxaemia; high fat meals; inflammation; oxidative stress
1. Introduction
Ageing is associated with dysfunction of the maintenance of cardiovascular and metabolic
health, likely aggravated by the current western lifestyle resulting in declining health and increase
chronic disease risk. Chronic low-grade inflammation is associated with ageing and contributes
to morbidity and mortality [1]. The immunosenescence associated with ageing [2] manifests as an
elevated basal immune status [3] along with insufficient immune activation after a challenge [4].
Evidence is mounting in support of chronic low-grade inflammation as a factor responsible in the
development of insulin resistance and type 2 diabetes mellitus (T2DM) [5], along with other chronic
illnesses such as cardiovascular disease or cancers [6] and, overall, as detrimental to healthy ageing [7].
Moreover, oxidative stress and inflammation contribute directly to the cellular senescence that helps
perpetuate the condition of immune decline in ageing [8,9]. Age-related differences in monocyte
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expression of genes has begun to establish a characteristic senescent profile in the elderly [10,11].
Genes, such as insulin-like growth factor-binding protein 3 (IGFBP3) [10], cluster of differentiation
(CD) 40 ligand CD40LG, and BCL2 agonist/killer 1 (BAK1) [11], are involved in cellular processes’
regulative cellular function, integrity, and responsiveness, and age-related changes in expression may
contribute to differences in immune responsiveness in ageing.
Acute inflammatory responses can be initiated by meals, particularly those high in fat.
The mechanisms of these postprandial inflammatory responses are highly reliant on the lipaemia
caused by increased chylomicron formation and triacylglyceride (TAG) content in circulation.
Chylomicron and TAG adherence to [12], and activation of, monocytes [13] provokes an acute
immune response. Additionally, bacterial translocation across the gut, facilitated by fat absorption and
chylomicron formation, triggers an immune response, manifesting as postprandial endotoxaemia [14].
The corresponding postprandial inflammatory state may further contribute to a systemic low-grade
inflammation [15], already typically prevalent in ageing populations [9].
These postprandial lipaemic and inflammatory responses are already documented as elevated
in metabolically-compromised adults, such as those displaying insulin resistance or T2DM [16–19],
conditions found more prevalently in older adults [20,21]. Postprandial endotoxaemia is reliant
on the formation of triacylglyceride-rich lipoproteins (TRL) [22–24], is evidently elevated in T2DM
subjects [25], and is associated with increased intestinal permeability [26]. Ageing has sometimes
been associated with digestive differences [27,28], changes to the gut microbiota [29], or gut barrier
function [30] which could, therefore, contribute to elevated postprandial endotoxaemia after a high
fat meal [31,32]. Furthermore, the exaggerated lipaemic response to high fat meals seen in older
adults [33–39], including prolonged appearance [37,39] and overproduction of TRL, would likely
contribute to greater postprandial endotoxaemia and inflammation in this population. Despite this
evidence, studies examining the postprandial inflammatory responses of healthy older adults have yet
to be conducted. Therefore, the aim of this study was to investigate the postprandial inflammatory
response to a high fat mixed meal in older adults compared to younger adults. To achieve this,
postprandial bacterial translocation was evaluated through measures of circulating endotoxin, acute
phase protein responses, and monocyte gene expression of pyrogen specific receptors. Additional
pathways of postprandial inflammatory activation were assessed through monocyte lipoprotein
receptor gene expression. The resultant regulation and production of cytokines and antioxidants were
examined, along with the senescent profile of monocytes. It was hypothesised that older adults would
have greater postprandial endotoxaemia and inflammation, characterised by greater TRL transport of
endotoxin and an exaggerated immune and oxidative stress response.
2. Materials and Methods
2.1. Subject Selection
Thirty healthy, community-dwelling subjects (n = 7 young females, n = 8 young males, n = 9
older females, n = 6 older males) from the Auckland region were recruited through local newspaper
advertising to participate between October 2012 and July 2013. Eligible subjects were required to
have a body mass index (BMI) between 18 and 30 kg/m2 and be between the ages of 20–25 years and
60–75 years. The original protocol to recruit older adults 70–75 was amended during recruitment due
to difficulty identifying subjects meeting the eligibility requirements. Individuals with a history of
cardiovascular or metabolic disease/conditions, or who used medications that may interfere with study
endpoints (i.e., anti-inflammatory drugs, statin drugs) were not eligible for participation. Participant
screening, enrolment, and randomisation are depicted in Figure 1.
This study was conducted according to the guidelines laid down by the Declaration of Helsinki
and all procedures involving human subjects were approved by the University of Auckland Human
Participants and Ethics Committee (Ref #8026). Written informed consent was obtained from all
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subjects. This study was registered with the Australian New Zealand Clinical Trials Registry
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Figure 1. Participant eligibility, enrolment, and randomisation. HF, the high‐fat meal; LF, the low fat 
meal. 
2.2. Study Design and Treatments 
In a randomised cross‐over design, subjects received two test meals in a random sequence and 
served as his/her own  control. Sequences were  randomly generated using www.random.org  [40] 
stratified by age group and allocated by concealed envelopes prior  to  the  first visit. The primary 
outcome  of  elevated  postprandial  lipaemia  in  the  elderly  has  been  presented  elsewhere  [41]. 
Inflammatory cytokine gene expression, circulating endotoxin, cytokines, and markers of oxidative 
stress were assessed as secondary outcomes. 
The high‐fat meal (HF) was chosen as a standard test meal with a high‐fat and protein load used 
previously  to  induce  a  postprandial  inflammatory  response  [42]  and  was  purchased  from 
McDonald’s Restaurants in Auckland. The low fat meal (LF) was protein‐ and carbohydrate‐matched 
to the HF meal based on standardly available nutritional information (Table 1) and was designed to 
follow the Australian Guide to Healthy Eating, while maintaining a low‐fat load. Subjects were not 
blinded to meal identities. 
Table 1. Macronutrient composition of high‐ and low‐fat breakfasts. 
Item Name  Weight (g)  Macronutrients (g) 1 Energy (kcal) 
Carbohydrates Fat Protein 
High fat breakfast 
Sausage and Egg Muffin Sandwich (×2)  162  25.2  21  23.4  390 
Hash Brown (×2)  56  13.5  10.1  1.5  150 
Total    77.4  62.2  49.8  1080 
Low fat breakfast 
Rolled Oats  37  20.8  1.9  5.0  120 
1% Cottage Cheese  167  4.5  1.0  19.7  110 
Mixed Grain Bread  42  11.2  2.2  5.1  90 
Reduced Fat Peanut Butter, Smooth  25  8.4  9.4  4.4  140 
Fresh Peach  154  14.6  0.3  1.4  60 
Trim Milk  365  17.9  1.8  14.2  150 
Total    77.4  16.6  49.8  670 
1 Values  presented  are  based  on  nutrient  panel  data  obtained  from  the website  of  the  fast  food 
restaurant and from packaging of the low fat breakfast items. 
Figure 1. Participant eligibility, enrolment, and randomisation. HF, the high-fat meal; LF, the low
fat meal.
2.2. Study Design and Treatments
In a randomised cross-over design, subjects received two test meals in a random sequence and
served as his/her own control. Sequences were randomly generated using www.random.org [40]
stratified by age group and allocated by concealed envelopes prior to the first visit. The primary
outcome of elevated postprandial lipaemia in the elderly has been presented elsewhere [41].
Inflammatory cytokine gene expression, circulating endotoxin, cytokines, and markers of oxidative
stress were assessed as secondary outcomes.
The high-fat meal (HF) was chosen as a standard test meal with a high-fat and protein load used
previously to induce a postprandial inflammatory response [42] and was purchased from McDonald’s
Restaurants in Auckland. The low fat meal (LF) was protein- and carbohydrate-matched to the HF
meal based on standardly available nutritional information (Table 1) and was designed to follow the
Australian Guide to Healthy Eating, while maintaining a low-fat load. Subjects were not blinded to
meal identities.
2.3. Study Procedures
Subjects were asked to abstain from vigorous physical activity, high-fat foods, and
anti-inflammatory medications and supplements the day prior to their visit to the Paykel Clinical
Trial Unit at the Liggins Institute. Subjects arrived fasted on two separate occasions a minimum of
14 days apart. Anthropometric data were collected before a catheter was inserted into an antecubital
vein and a baseline sample (time 0) was taken followed by consumption of the test breakfast. Blood
samples were collected hourly for 5 h post-meal in blood collection tubes (Becton Dickinson, Franklin
Lakes, NJ, USA) for serum and ethylenediaminetetraacetic acid (EDTA) plasma, and processed as
described previously [43]. Plasma supernatants were processed under laminar flow using pyrogen-free
consumables. Pl sma for chylomicron separation was kept at 4 ◦C and processed within 6 h and the
remaining plasma was collected in pyrogen-free microtubes and stored at −20 ◦C.
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Table 1. Macronutrient composition of high- and low-fat breakfasts.
Item Name Weight (g)
Macronutrients (g) 1
Energy (kcal)
Carbohydrates Fat Protein
High fat breakfast
Sausage and Egg Muffin Sandwich (×2) 162 25.2 21 23.4 390
Hash Brown (×2) 56 13.5 10.1 1.5 150
Total 77.4 62.2 49.8 1080
Low fat breakfast
Rolled Oats 37 20.8 1.9 5.0 120
1% Cottage Cheese 167 4.5 1.0 19.7 110
Mixed Grain Bread 42 11.2 2.2 5.1 90
Reduced Fat Peanut Butter, Smooth 25 8.4 9.4 4.4 140
Fresh Peach 154 14.6 0.3 1.4 60
Trim Milk 365 17.9 1.8 14.2 150
Total 77.4 16.6 49.8 670
1 Values presented are based on nutrient panel data obtained from the website of the fast food restaurant and from
packaging of the low fat breakfast items.
2.4. Chylomicron Isolation
Chylomicron separation was performed using gamma irradiated 4.7 mL OptiSeal tubes (Beckman
Coulter, Brea, CA, USA) in an Optima™ MAX-XP model ultracentrifuge using a TLA-110 rotor,
as described previously [44]. Density gradient solutions were prepared with 0.005% EDTA using
pyrogen-free water according to Naito [45] and separation protocols were based on those of Kupke and
Wörz-Zeugner [46]. Chylomicrons were separated by overlaying 3.5 mL plasma with 1.2 mL saline
solution (density = 1.006 g/mL) and centrifuging at 117,000× g for 10 min. The visible chylomicron top
layer was aspirated into pyrogen-free microtubes and corrected to a final collection volume of 1.4 mL
using pyrogen-free saline solution to provide a standardised dilution factor. Chylomicron fractions
were stored at −80 ◦C.
2.5. PBMC Isolation and RNA Extraction
Whole blood (2 mL), collected from EDTA blood collection tubes (Becton Dickinson, Franklin
Lakes, NJ, USA) at 0, 2, and 4 h, was layered over 2 mL of Histopaque solution (Sigma-Aldrich,
St. Louis, MO, USA) and centrifuged for 30 min at 400× g at room temperature. PBMCs were removed
from the interface, washed twice with phosphate buffered saline (PBS), and RNA was extracted
(Purelink RNA Mini Kit, Life Technologies, Waltham, MA, USA). DNA contamination was eliminated
by DNase digestion from the cell lysate prior to RNA isolation. RNA concentration was measured
using a NanoDrop (ND-1000 Spectrophotometer, Thermo Scientific, Waltham, MA, USA). RNA was
reverse transcribed using a High Capacity RNA-to-cDNA Kit (Life Technologies, Waltham, MA, USA)
as per the manufacturer’s instructions.
2.6. Quantitative Real-Time Reverse-Transcriptase Polymerase Chain Reaction (qPCR) Analysis
qPCR was performed using a LightCycler 480 (Roche Applied Science, Penzberg, Germany)
using SYBR™ Green I DNA-binding dye. The geometric mean of human β-Actin, glyceraldehyde
3-phosphate dehydrogenase (GAPDH), and RNA18S genes was used as the endogenous control.
Primers (Table S1) were obtained from Invitrogen (Life Technologies, Waltham, MA, USA). Samples
were run in duplicate 10 µL reaction volumes with 1.25 ng cDNA per reaction. Results are expressed
as absolute gene expression using the 2−∆Cp method [47].
2.7. Biochemical Analysis
Biochemical measures of baseline plasma total cholesterol, low density lipoproteins (LDL) and
high density lipoproteins (HDL), and postprandial triacylglycerides, glucose, and serum C-reactive
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protein (CRP) were carried out using a Hitachi 902 autoanalyser (Hitachi High Technologies
Corporation, Tokyo, Japan) by enzymatic colorimetric assay (Roche, Mannheim, Germany).
Postprandial plasma insulin was measured using an Abbott AxSYM system (Abbott Laboratories,
Abbott Park, IL, USA) by microparticle enzyme immunoassay. The acute phase protein, plasma
lipopolysaccharide binding protein (LBP), was assessed using a commercially available ELISA kit
for quantification of human LBP (Abnova, Jhongli, Taiwan) at 0, 1, 2, and 3 h only, based on the
postprandial responses reported by others [42]. Plasma inflammatory markers (n = 7 younger,
n = 6 older), including tumour necrosis factor-alpha (TNF-α), monocyte chemotactic protein-1 (MCP-1),
interleukin-1β (IL-β), and interleukin-6 (IL-6), were analysed using a flow cytometric multiplex array
(Milliplex MAP Kit Human Cytokine Magnetic Bead Panel Assay, Millipore, Billerica, MA, USA) after
the HF breakfast only, at 0, 2, and 4 h time points only matching with postprandial RNA analysis time
points. Similarly, total superoxide dismutase (SOD) activity and total antioxidant status (TAS) were
measured after the HF breakfast only, at 0, 2, and 4 h time points only, matching with postprandial RNA
analysis time points, using commercial assay kits as per the manufacturer’s instructions (Sapphire
Bioscience, Melbourne, Australia).
2.8. Endotoxin Analysis
Plasma and chylomicron endotoxin concentrations were determined (n = 12/group) using the
Kinetic-QCL chromogenic Limulus Amebocyte Lysate (LAL) assay (Lonza, Cleveland, TN, USA)
as per the manufacturer’s instructions. Chylomicron samples were diluted 1:100 with LAL reagent
water (LRW) and heat inactivated at 70 ◦C for 10 min. Plasma samples were acid treated to remove
inhibitory plasma proteins as described by Ketchum and Novitsky [48] in reagents prepared in LRW.
In brief, samples were treated with 1.32 N nitric acid, heat treated at 37 ◦C for 5 min and centrifuged at
1500× g for 5 min. The supernatant was removed and neutralised with 0.55 N NaOH before dilution
to 1:100 with LRW. The endotoxin concentration was expressed as endotoxin units (EU)/mL.
2.9. Statistical Analyses
The homeostatic model assessment of insulin resistance (HOMA-IR) was calculated from fasting
glucose and insulin concentrations using the equation from Matthews et al. [49]. Maximum peak times
(Tmax) were identified as the nominal sampling time corresponding with peak concentration. Sample
size calculations have been described elsewhere for a primary outcome of postprandial lipaemia [41];
these were estimated to detect with 80% power a between-subject TAG incremental AUC (iAUC)
difference of 4.77 mmol/L per h [35] with a significance level of p ≤ 0.05. Statistical analyses were
conducted with SPSS (IBM, Armonk, NY, USA, version 21). Data are presented as means ± standard
error of the mean (SEM), except Tmax which is presented as median and interquartile range (IQR).
Baseline concentrations were compared using two-way analysis of variance (ANOVA, treatment
compared within-subject and age compared between subject). Tmax was compared using a generalised
estimation equation (GEE) with SPSS. The link identity was cumulative probit and an unstructured
covariance matrix (UN); for binary variables (meal and age) a probit model was used. Protein
expression of CRP, cytokines, and antioxidants were compared using two-factor repeated-measures
ANOVA (time compared within-subject and age compared between subject), while three-factor
repeated-measures ANOVA was used for all other analyses (treatment and time each compared
within-subject and age compared between subject). Sidak post hoc tests were used for all multiple
comparisons between groups. Where Mauchly’s sphericity test failed, the Huynh-Feldt correction was
applied. Alpha was set at p < 0.05. Figures were generated with GraphPad Prism (GraphPad Software
Inc., La Jolla, CA, USA, version 6.01).
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3. Results
3.1. Subject Characteristics
There were no age differences for fasting measurements of BMI, plasma glucose, insulin,
triglycerides, or HOMA-IR. Older subjects had higher fasting total cholesterol, LDL and HDL (p < 0.001,
p = 0.008, and p < 0.001, respectively; Table 2). Differences in postprandial lipaemia are reported
elsewhere [41]. In brief, older participants showed exaggerated and prolonged postprandial elevations
of TAG. There were no differences in TAG iAUC between older and younger subjects after either meal,
but iAUC was lower after the LF meal in both groups (treatment effect p < 0.05). However, the time to
maximum TAG concentration (Tmax) was greater for older adults compared to younger adults after
both the HF and LF meals (Tmax HF 3 (IQR 3–4) vs. 2 (IQR 1.5–3) h and Tmax LF 4 (IQR 3–5) vs. 3 (IQR
2–3) h for older vs. younger subjects, respectively; age effect p < 0.05).
Table 2. Baseline subject characteristics.
Measure 1 Unit Younger Subjects (n = 15) 2 Older Subjects (n = 15) 2,3
Age years 22.7 ± 0.4 67.3 ± 1.5 ***
BMI kg/m2 23.7 ± 0.8 24.4 ± 1.0
Glucose mmol/L 5.1 ± 0.1 5.2 ± 0.1
HOMA-IR 2.1 ± 0.2 1.9 ± 0.2
Cholesterol mmol/L 4.0 ± 0.1 5.0 ± 0.1 ***
LDL mmol/L 2.5 ± 0.1 3.0 ± 0.1 **
HDL mmol/L 1.3 ± 0.0 1.8 ± 0.1 ***
TAG mmol/L 0.8 ± 0.0 0.9 ± 0.0
Insulin µU/mL 9.2 ± 0.8 8.7 ± 1.2
1 BMI: body mass index; HOMA-IR: homeostatic model assessment of insulin resistance; LDL: low density
lipoproteins; HDL: high density lipoproteins; TAG: triacylglyceride; 2 Values presented as means± standard error of
the mean (SEM) over both treatments; 3 Main effects and interactions were analysed by two-factor repeated-measures
analysis of variance (ANOVA; treatment and age). There were no differences between group baseline values between
treatment days; *** p < 0.001, ** p < 0.01 compared with younger subjects.
3.2. Postprandial Endotoxaemia
Plasma endotoxin concentration did not differ in the postprandial period (Figure 2a). Postprandial
endotoxaemia tended to be greater after the HF breakfast (p = 0.156), with no evident impact of
age (p = 0.84). Although endotoxaemia did not differ with age, older subjects tended to have
prolonged endotoxaemia after 3 h (p = 0.059) while the younger group did not. Chylomicron endotoxin
concentration tended to differ between breakfast treatments (p = 0.061) and treatment differences
tended to depend on time (p = 0.097; Figure 2b). Chylomicron endotoxaemia after the HF breakfast
varied more greatly between subjects, and post hoc analysis revealed a tendency towards greater
differences at baseline between study visits, and at 1 and 4 h after the meal (p = 0.064, p = 0.052, and
p = 0.133, respectively). Changes in LBP concentration differed between treatments and age groups
(p = 0.013, Figure 2c). Older subjects had greater LBP concentrations at baseline and 1 h during the
LF challenge than during the HF breakfast (p = 0.008 and 0.036, respectively). This corresponded
with higher LBP concentrations in the older participants at baseline and 1 h during the LF challenge
(p = 0.017 and p = 0.024 respectively). With the higher baseline concentration in older participants
before the LF meal, the older group experienced a significant decrease in LBP concentration by 2 h
post-meal (baseline vs. 2 h; p = 0.016). The younger group had higher concentrations of LBP at 3 h
after the LF than after the HF breakfast.
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Figure 2. Endotoxin and lipopolysaccharide binding protein (LBP) responses to high-fat (HF) and
low-fat (LF) breakfasts in older and younger subjects. Older high-fat (filled squares), older low-fat (open
squares), younger high-fat (filled circles), younger low-fat (open circles). Values represent mean ± SEM in
EU/mL for plasma endotoxin ((a); n = 12/group) and chylomicron endotoxin ((b); n = 12/group) and
in µg/mL for LBP ((c); n = 15/group). There were no differences in plasma or chylomicron endotoxin
responses between older and younger subjects. There were significant differences in the LBP response
over time, dependent on age and treatment (age × time × treatment interaction of p < 0.05, three-factor
repeated-measures ANOVA). ε p < 0.05 age difference after LF; § p < 0.05 treatment difference in older
subjects; φ p < 0.05 treatment difference in younger subjects; † p < 0.05 time difference after LF in older
subjects (Sidak corrected post hoc tests).
3.3. PBMC Senescence RNA Expression
IGFBP3 expression was greater in the older group (p = 0.001) and tended to be higher before
the LF meal (p = 0.073) causing a significant time-treatment interaction (p = 0.005; Figure 3a). BAK1
expression was no different between groups and did not differ with feeding (Figure 3b). Both groups
had increased CD40LG expression at 4 h after both meals (p = 0.002; Figure 3c).
3.4. PBMC RNA Expression of Endotoxaemic Activation
Younger subjects had decreased CD14 expression at 4 h compared to 2 h (p = 0.005; Figure 3d),
while older subjects showed no changes after meal ingestion. Toll-like receptor (TLR) 2 (TLR2) response
was no different between groups after either meal but was higher at 2 h than 4 h (p = 0.002; Figure 3e).
TLR9 expression tended to be lower overall in older participants (p = 0.055; Figure 3f).
3.5. PBMC RNA Expression of Activation by Lipoproteins
No change in ATP-binding cassette transporter 1 (ABCA-1) expression was observed after either
meal in either age group (Figure 3g). Apolipoprotein B48 receptor (ApoB48r) expression tended to
be higher in older participants (p = 0.111), higher after the LF meal (p = 0.087) and higher at baseline
(p = 0.15; Figure 3h). The older group had lower LDL receptor (LDLr) expression (p = 0.038; Figure 3i).
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Figure 3. Relative senescence-related, endotoxaemia-related and lipid receptor peripheral blood
mononuclear cells (PBMC) gene expression responses to high-fat (HF) and low-fat (LF) breakfasts in
older and younger subjects. Older high-fat (filled squares), older low-fat (open squares), younger high-fat
(filled circles), younger low-fat (open circles). Values represent mean ± SEM (n = 15/group) in arbitrary
units (AU) for IGFBP3 (a), BAK1 (b), CD40LG (c), CD14 (d), TLR2 (e), TLR9 (f), ABCA-1 (g), ApoB48r
(h), and LDLr (i), respectively. There were no differences in BAK1 TLR2, TLR9, ABCA-1, or ApoB48r
responses between older and younger adults. There were significant age differences in LDLr gene
expression (age effect of p < 0.05) and changes over time for CD40LG and TLR2 (time effect of p < 0.05
and p < 0.01, respectively). There were significant age differences and time differences, dependent
on treatment in the IGFBP3 response (time × treatment interaction of p < 0.01, age effect of p < 0.01,
three-factor repeated-measures ANOVA). CD14 expression was significantly different between older
and younger adults over time (time × age interaction of p < 0.05). a p < 0.05 main age difference;
** p < 0.01 change from baseline; λ p < 0.05 time difference in younger subjects; γ p < 0.01 time difference
(Sidak corrected post hoc tests).
3.6. PBMC Inflammatory Cytokine Gene Expression
IL-1β expression changed after meal ingestion (p = 0.03) and tended to decrease compared to
baseline (p = 0.107). MCP-1 expression did not change after meal ingestion and the response was
similar between age groups (Figure 4a,b). TNF-α expression increased over time (p = 0.033; Figure 4c),
but was not different between breakfasts or age groups.
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Figure 4. Relative inflammatory cytokine and oxidative stress peripheral blood mononuclear cells
(PBMC) gene expression responses to high-fat (HF) and low-fat (LF) breakfasts in older and younger
subjects. Older high-fat (filled squares), older low-fat (open squares), younger high-fat (filled circles), and
younger low-fat (open circles). Values represent mean ± SEM (n = 15/group) in arbitrary units (AU)
for IL-1β (a), MCP-1 (b), TNF-α (c), GPX-1 (d), and SOD-2 (e), respectively. There were no differences
in IL-1β, MCP-1, or TNF-α, responses between older and younger subjects. There were significant
age differences in GPX-1 gene expression (age effect of p < 0.05 each respectively) and changes over
time for IL-1β and TNF-α (time effect of p < 0.05 each respectively). The SOD-2 response differed over
time, dependent on age and treatment (age × time × treatment interaction of p < 0.05, three-factor
repeated-measures ANOVA). a p < 0.05 main age difference; * p < 0.05 change from baseline; ε p < 0.05
age difference after LF; § p < 0.05 treatment difference in older subjects; ‡ p < 0.05 time difference after
HF in older subjects (Sidak corrected post hoc tests).
3.7. PBMC RNA Expression of Oxidative Stress Response
Younger subjects had higher glutathione peroxidase 1 (GPX-1) expression (p = 0.014; Figure 4d),
however, this did not change after either meal. SOD-2 expression decreased at 2 and 4 h after meal
ingestion in the older group, but not the younger group (p < 0.001; Figure 4e). For this reason, older
subjects had lower SOD-2 expression at 2 and 4 h compared to younger subjects (p = 0.044 and p =
0.004, respectively).
3.8. Cytokine and Antioxidant Protein Expression
There were no differences between age groups in postprandial concentrations of serum CRP
(p = 0.84, Figure 5a), and plasma IL-1β (p = 0.436), IL-6, and TNF-α (Figure 5b,d; p = 0.111 and
p = 0.112 respectively), although IL-6 and TNF-α tended to be higher in older participants. Cytokine
concentrations measured for IL-1β and IL-6 were very low with reference to the standard curve, and
IL-6 (but not IL-1β) increased between baseline and 4 h in both age groups (p = 0.007). IL-1β did not
change after the meal for older or younger subjects (p = 0.336 time effect; iAUC −87.9 ± 90.0 (older
subjects) vs. −19.8 ± 12.7 (younger subjects); p = 0.504). MCP-1 concentration was higher in the older
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group (p = 0.028, Figure 5c), and unchanged with meal ingestion. SOD activity and TAS were not
different between age groups nor affected by HF meal ingestion (Figure 5d,e).
Nutrients 2017, 9, 354  9 of 15 
 
younger low‐fat (open circles). Values represent mean ± SEM (n = 15/group) in arbitrary units (AU) for 
IL‐1β (a), MCP‐1 (b), TNF‐α (c), GPX‐1 (d), and SOD‐2 (e), respectively. There were no differences in 
IL‐1β, MCP‐1, or TNF‐α, responses between older and younger subjects. There were significant age 
differences in GPX‐1 gene expression (age effect of p < 0.05 each respectively) and changes over time 
for IL‐1β and TNF‐α (time effect of p < 0.05 each respectively). The SOD‐2 response differed over time, 
dependent on age and treatment (age × time × treatment interaction of p < 0.05, three‐factor repeated‐
measures ANOVA).  a p < 0.05 main age difference;  * p < 0.05 change  from baseline;  ɛ p < 0.05 age 
difference after LF; § p < 0.05 treatment difference in older subjects; ‡ p < 0.05 time difference after HF 
in older subjects (Sidak corrected post hoc tests). 
3.7. PBMC RNA Expression of Oxidative Stress Response 
Younger subjects had higher glutathione peroxidase 1 (GPX‐1) expression (p = 0.014; Figure 4d), 
however, this did not change after either meal. SOD‐2 expression decreased at 2 and 4 h after meal 
ingestion in the older group, but not the younger group (p < 0.001; Figure 4e). For this reason, older 
subjects had lower SOD‐2 expression at 2 and 4 h compared to younger subjects (p = 0.044 and p = 
0.004, respectively). 
3.8. Cytokine and Antioxidant Protein Expression 
There were no differences between age groups in postprandial concentrations of serum CRP (p 
= 0.84, Figure 5a), and plasma IL‐1β (p = 0.436), IL‐6, and TNF‐α (Figure 5b,d; p = 0.111 and p = 0.112 
respectively),  although  IL‐6  and  TNF‐α  tended  to  be  higher  in  older  participants.  Cytokine 
concentrations measured for IL‐1β and IL‐6 were very low with reference to the standard curve, and 
IL‐6 (but not IL‐1β) increased between baseline and 4 h in both age groups (p = 0.007). IL‐1β did not 
change after the meal for older or younger subjects (p = 0.336 time effect; iAUC −87.9 ± 90.0 (older 
subjects) vs. −19.8 ± 12.7 (younger subjects); p = 0.504). MCP‐1 concentration was higher in the older 
group (p = 0.028, Figure 5c), and unchanged  ith  eal  ingestion. S  activity and T S  ere not 
different bet een age groups nor affected by HF meal ingestion (Figure 5d,e). 
 
Figure 5. Circulating C-reactive protein, cytokine protein concentrations, and antioxidant status in
older and younger subjects after the high-fat breakfast only. C-reactive protein (CRP), superoxide
dismutase activity (SOD), and total antioxidant status (TAS, n = 15/group), and cytokine protein
concentrations in older (filled squares, n = 7) and younger adults (filled circles, n = 6), respectively. Values
represent mean ± SEM for CRP (a) in mg/L, IL-6 (b) in pg/mL, MCP-1 (c) in pg/mL, TNF-α (d) in
pg/mL, SOD (e) in U/mL, and TAS (f) in mM. There were no differences in CRP, IL-6, TNF-α, SOD,
and TAS responses between older and younger subjects. There were significant age differences in
MCP-1 protein concentrations (age effect of p < 0.05) and changes over time for IL-6 (time effect of
p < 0.01, two-factor repeated-measures ANOVA). a p < 0.05 main age difference; * p < 0.05 change from
baseline; γ p < 0.01 time difference (Sidak corrected post hoc tests).
4. Discussion
This study demonstrates that in an otherwise healthy older cohort, postprandial inflammation
is not exaggerated compared to younger adults. Our results indicate that baseline differences in
immune status may be present in healthy older adults, but that any such differences are not associated
with differences in the postprandial immune response to a high fat meal. The similarities in immune
response between older and younger adults are in spite of exaggerated postprandial lipaemia in these
older subjects [41] and suggest that the inflammatory response to a high-fat meal is not exacerbated in
older age despite age-related differences in the basal immune profile.
Previous studies have shown that a high-fat meal induces postprandial inflammation;
however, the magnitude and the specific measurable markers of this inflammation varies between
studies [50], and are reliant on the precise meal components included [51–54], as well as
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the health status of subjects [16]. Inflammatory gene expression [16], plasma cytokines [18],
and endotoxaemia [25] are reported to be particularly elevated after high-fat or high-caloric
meals [55] in metabolically-compromised adults, such as those with T2DM and metabolic
syndrome. These acute meal responses may contribute to a state of chronic low-grade inflammation,
accelerating the development of insulin resistance and cardiovascular disease through progression
of atherosclerosis [56,57]. To our surprise, no marked difference in postprandial endotoxaemia or
inflammation was seen between younger and older subjects in the current study, suggesting that older
adults do not display a greater acute inflammatory response to ingestion of a single high-fat meal.
Postprandial inflammation is elevated after a high fat meal in part due to monocyte activation
by circulating lipoproteins resulting from postprandial lipaemia [58]. Although older adults have
increased numbers of circulating TRLs [41], we found that this did not correspond with higher
postprandial gene expression of monocyte lipoprotein receptors, apoB48r and LDLr, suggesting no
greater postprandial potential for monocyte activation by lipoproteins in older adults. Metabolically,
greater insulin resistance is associated with greater postprandial endotoxaemia [25,59]; as HOMA-IR
was not different between older and younger participants, this supports the idea that the two conditions
may be linked, and may explain the absence of postprandial endotoxaemia in these older subjects.
Our results suggest that despite the higher incidence of insulin resistance or hyperlipidaemia typical
in older adults, and the greater postprandial inflammatory effects of these conditions [16,25], older
individuals free from metabolic dysfunction do not experience greater postprandial inflammation.
Along with metabolic effects on postprandial inflammation, gut barrier function may have a
crucial role in regulating the immune response to a high fat meal. Postprandial endotoxaemia is
increased after a high-fat meal [60] corresponding with elevated lipaemia [24,42], a finding recently
linked to direct chylomicron translocation of endotoxin [14,22,23,42]. Although the absorptive and
immune function of the gut has been suggested to be impaired with ageing [61,62], our finding of equal
postprandial plasma and chylomicron endotoxaemia between older and younger adults contradicts
this notion, and supports the concept that ageing itself does not conclusively impair gut barrier
function [27,28]. Furthermore, this suggests that older adults in the current study had maintained gut
barrier function in spite of exaggerated chylomicronaemia.
The postprandial immune response to endotoxin is initiated by acute LBP production [42],
which also facilitates the endotoxaemic immune response by activation of NF-κB through CD14 and
TLR4, while other bacterial components act through TLR2 [63] and TLR9. Corresponding with no
postprandial age differences in endotoxaemia, we saw no greater postprandial LBP concentration or
induction of PBMC genes involved in bacterial immune defence in older participants after a high-fat
meal. Furthermore, the typical [64] basal elevation of LBP in older subjects did not contribute to a
greater endotoxaemic response, indicating that an elevated immune status in these individuals does
not increase the magnitude of postprandial endotoxaemia. Similarly, postprandial cytokine genes
and protein expression were no different between age groups, indicating no deficit or elevation in
postprandial immune response associated with ageing.
Oxidative stress is also suggested to contribute to the postprandial inflammatory response
through cytokine production [65,66]. Although IL-6 concentrations were elevated after meal ingestion,
this change was equal between age groups. Despite the age similarity in cytokine response, older
participants had lower SOD-2 gene expression which decreased after the high fat meal while younger
subjects maintained expression levels equal to baseline, similar to other reports [67]. However, while
the age differences in gene expression may suggest an inadequate postprandial antioxidant response
in older adults, protein antioxidant expression of SOD activity and TAS were no different between
age groups. As absolute protein responses do not appear to be compromised in these older subjects,
compensatory mechanisms to maintain adequate antioxidant responsiveness may be at play in the
healthy elderly. Increased postprandial GPX-1 expression has been reported following a meal high in
saturated fat as a response to increased reactive oxygen species production [68]. As we also reported
lower baseline GPX-1 expression that was maintained after the ingestion of either meal, these older
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subjects may have lower antioxidant capacity, which suggests that basal immune status may contribute
to postprandial antioxidant capacity but not necessarily immune response in older individuals.
While the lack of elevated immune response to a high-fat meal in older participants likely indicates
no impairment of acute activation, we investigated the possibility that immunosenescence could also
elicit such a moderate acute immune responsiveness, particularly since oxidative stress has been
associated with cellular immunosenescence [8,9]. Analysis of expression of genes associated with
immunosenescence, such as impaired apoptosis regulation (BAK1) and cellular immune activation
(CD40LG) [11], indicated no obvious impairment of the immune response in these older subjects.
The elevated expression of IGFBP3 that we observed is typical of the senescence profile reported in
older adults [10], and suggests that, despite characteristic cellular senescent changes in these older
adults, postprandial immune activation remains unaffected.
5. Conclusions
Our results highlight that, despite typically elevated postprandial lipaemia, otherwise
metabolically-healthy older adults do not have an exaggerated postprandial immune or endotoxaemic
response to a standard high-fat mixed meal. These findings provide the first description of the
comparative evaluation of postprandial immune responses in older adults. These findings indicate
that the basal health and metabolic status of older adults should be considered as a confounding factor
in the study of postprandial immune responses in an ageing population, since these healthy elderly
show no impairment of postprandial response. This suggests that the maintenance of health status into
older age may be protective against the detrimental effects of acute high fat meal ingestion, and that
older adults are at no greater risk than younger adults for chronic low-grade inflammation initiated by
fat ingestion.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/9/4/354/s1,
Table S1: Primer sequences for targeted peripheral blood mononuclear cell (PBMC) gene expression.
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